As personalized therapies have become a reality rather than a distant promise, the tools needed to ensure the quality of these medicines grow increasingly important. Regulatory guidances for personalized medicines are frequently a “work in progress,” evolving over time as the body of knowledge grows for ensuring that these therapies are safe and beneficial.
USP is the logical choice for consistency and reproducibility in reference standards for biologics.
USP’s biologics blog delivers trends and insights impacting the development, manufacture and regulatory approval of biologics and biosimilars. Updated regularly, the blog covers a broad range of topics of interest to anyone working in the field of biopharmaceuticals.
We invite you to subscribe today and receive a regular email summary of our blog posts.